Logo image of CZR

CAESARS ENTERTAINMENT INC (CZR) Stock Fundamental Analysis

USA - NASDAQ:CZR - US12769G1004 - Common Stock

20.288 USD
-0.32 (-1.56%)
Last: 11/18/2025, 9:40:08 AM
Fundamental Rating

2

Overall CZR gets a fundamental rating of 2 out of 10. We evaluated CZR against 132 industry peers in the Hotels, Restaurants & Leisure industry. CZR may be in some trouble as it scores bad on both profitability and health. CZR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CZR had negative earnings in the past year.
CZR had a positive operating cash flow in the past year.
In the past 5 years CZR reported 4 times negative net income.
Of the past 5 years CZR 4 years had a positive operating cash flow.
CZR Yearly Net Income VS EBIT VS OCF VS FCFCZR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

With a Return On Assets value of -0.76%, CZR is not doing good in the industry: 68.94% of the companies in the same industry are doing better.
CZR's Return On Equity of -6.37% is in line compared to the rest of the industry. CZR outperforms 44.70% of its industry peers.
CZR has a Return On Invested Capital (5.49%) which is in line with its industry peers.
CZR had an Average Return On Invested Capital over the past 3 years of 5.76%. This is below the industry average of 10.59%.
Industry RankSector Rank
ROA -0.76%
ROE -6.37%
ROIC 5.49%
ROA(3y)-0.39%
ROA(5y)-1.74%
ROE(3y)-4.54%
ROE(5y)-14.28%
ROIC(3y)5.76%
ROIC(5y)4.32%
CZR Yearly ROA, ROE, ROICCZR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

The Operating Margin of CZR (18.13%) is better than 76.52% of its industry peers.
In the last couple of years the Operating Margin of CZR has grown nicely.
Looking at the Gross Margin, with a value of 47.49%, CZR is in line with its industry, outperforming 51.52% of the companies in the same industry.
CZR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.13%
PM (TTM) N/A
GM 47.49%
OM growth 3Y4.31%
OM growth 5Y2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.56%
CZR Yearly Profit, Operating, Gross MarginsCZR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CZR is creating some value.
The number of shares outstanding for CZR has been reduced compared to 1 year ago.
CZR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CZR has a worse debt to assets ratio.
CZR Yearly Shares OutstandingCZR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CZR Yearly Total Debt VS Total AssetsCZR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.51, we must say that CZR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.51, CZR is not doing good in the industry: 74.24% of the companies in the same industry are doing better.
CZR has a debt to FCF ratio of 65.59. This is a negative value and a sign of low solvency as CZR would need 65.59 years to pay back of all of its debts.
CZR has a worse Debt to FCF ratio (65.59) than 60.61% of its industry peers.
A Debt/Equity ratio of 6.54 is on the high side and indicates that CZR has dependencies on debt financing.
CZR has a Debt to Equity ratio of 6.54. This is in the lower half of the industry: CZR underperforms 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.54
Debt/FCF 65.59
Altman-Z 0.51
ROIC/WACC1.07
WACC5.13%
CZR Yearly LT Debt VS Equity VS FCFCZR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

CZR has a Current Ratio of 0.78. This is a bad value and indicates that CZR is not financially healthy enough and could expect problems in meeting its short term obligations.
CZR's Current ratio of 0.78 is on the low side compared to the rest of the industry. CZR is outperformed by 60.61% of its industry peers.
A Quick Ratio of 0.76 indicates that CZR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.76, CZR is in line with its industry, outperforming 43.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.76
CZR Yearly Current Assets VS Current LiabilitesCZR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

The earnings per share for CZR have decreased by -1.77% in the last year.
The Revenue has been growing slightly by 0.87% in the past year.
The Revenue has been growing by 34.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-575%
Revenue 1Y (TTM)0.87%
Revenue growth 3Y5.52%
Revenue growth 5Y34.78%
Sales Q2Q%-0.17%

3.2 Future

CZR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 49.36% yearly.
The Revenue is expected to grow by 3.09% on average over the next years.
EPS Next Y-67.93%
EPS Next 2Y62.19%
EPS Next 3Y51.07%
EPS Next 5Y49.36%
Revenue Next Year1.99%
Revenue Next 2Y2.42%
Revenue Next 3Y2.37%
Revenue Next 5Y3.09%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CZR Yearly Revenue VS EstimatesCZR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B
CZR Yearly EPS VS EstimatesCZR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5 -10

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CZR. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 43.47, the valuation of CZR can be described as expensive.
Based on the Price/Forward Earnings ratio, CZR is valued a bit more expensive than the industry average as 60.61% of the companies are valued more cheaply.
CZR's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 34.62.
Industry RankSector Rank
PE N/A
Fwd PE 43.47
CZR Price Earnings VS Forward Price EarningsCZR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CZR is valued a bit cheaper than 77.27% of the companies in the same industry.
CZR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CZR is cheaper than 90.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.13
EV/EBITDA 8.14
CZR Per share dataCZR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

CZR's earnings are expected to grow with 51.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.19%
EPS Next 3Y51.07%

0

5. Dividend

5.1 Amount

CZR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CAESARS ENTERTAINMENT INC

NASDAQ:CZR (11/18/2025, 9:40:08 AM)

20.288

-0.32 (-1.56%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)10-28 2025-10-28/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners106.67%
Inst Owner Change-11.5%
Ins Owners0.93%
Ins Owner Change0.07%
Market Cap4.22B
Revenue(TTM)11.37B
Net Income(TTM)-241.00M
Analysts79.13
Price Target42.23 (108.15%)
Short Float %17.36%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-637.4%
Min EPS beat(2)-888.04%
Max EPS beat(2)-386.76%
EPS beat(4)1
Avg EPS beat(4)-330.33%
Min EPS beat(4)-888.04%
Max EPS beat(4)136.94%
EPS beat(8)1
Avg EPS beat(8)-445.26%
EPS beat(12)2
Avg EPS beat(12)-1152.35%
EPS beat(16)3
Avg EPS beat(16)-897.14%
Revenue beat(2)1
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-1.78%
Max Revenue beat(2)0.52%
Revenue beat(4)1
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-1.78%
Max Revenue beat(4)0.52%
Revenue beat(8)1
Avg Revenue beat(8)-1.88%
Revenue beat(12)3
Avg Revenue beat(12)-1.1%
Revenue beat(16)5
Avg Revenue beat(16)-0.95%
PT rev (1m)-1.73%
PT rev (3m)-2.97%
EPS NQ rev (1m)-218.63%
EPS NQ rev (3m)-170.18%
EPS NY rev (1m)-72.37%
EPS NY rev (3m)-1514.25%
Revenue NQ rev (1m)-0.88%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-0.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 43.47
P/S 0.37
P/FCF 11.13
P/OCF 3.23
P/B 1.12
P/tB N/A
EV/EBITDA 8.14
EPS(TTM)-1.15
EYN/A
EPS(NY)0.47
Fwd EY2.3%
FCF(TTM)1.82
FCFY8.98%
OCF(TTM)6.28
OCFY30.97%
SpS54.66
BVpS18.18
TBVpS-52.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.76%
ROE -6.37%
ROCE 6.95%
ROIC 5.49%
ROICexc 5.65%
ROICexgc 11.46%
OM 18.13%
PM (TTM) N/A
GM 47.49%
FCFM 3.33%
ROA(3y)-0.39%
ROA(5y)-1.74%
ROE(3y)-4.54%
ROE(5y)-14.28%
ROIC(3y)5.76%
ROIC(5y)4.32%
ROICexc(3y)5.94%
ROICexc(5y)4.47%
ROICexgc(3y)12.3%
ROICexgc(5y)9.19%
ROCE(3y)7.29%
ROCE(5y)5.47%
ROICexgc growth 3Y12.39%
ROICexgc growth 5Y-1.47%
ROICexc growth 3Y12.76%
ROICexc growth 5Y-4.07%
OM growth 3Y4.31%
OM growth 5Y2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.56%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 6.54
Debt/FCF 65.59
Debt/EBITDA 7.11
Cap/Depr 65.44%
Cap/Sales 8.16%
Interest Coverage -12.49
Cash Conversion 37.57%
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.76
Altman-Z 0.51
F-Score5
WACC5.13%
ROIC/WACC1.07
Cap/Depr(3y)93.85%
Cap/Depr(5y)77.92%
Cap/Sales(3y)10.59%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-575%
EPS Next Y-67.93%
EPS Next 2Y62.19%
EPS Next 3Y51.07%
EPS Next 5Y49.36%
Revenue 1Y (TTM)0.87%
Revenue growth 3Y5.52%
Revenue growth 5Y34.78%
Sales Q2Q%-0.17%
Revenue Next Year1.99%
Revenue Next 2Y2.42%
Revenue Next 3Y2.37%
Revenue Next 5Y3.09%
EBIT growth 1Y-12.26%
EBIT growth 3Y10.07%
EBIT growth 5Y38.4%
EBIT Next Year70.6%
EBIT Next 3Y22.21%
EBIT Next 5Y15.22%
FCF growth 1Y-43.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.38%
OCF growth 3Y-3.11%
OCF growth 5Y28.03%

CAESARS ENTERTAINMENT INC / CZR FAQ

What is the ChartMill fundamental rating of CAESARS ENTERTAINMENT INC (CZR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CZR.


What is the valuation status of CAESARS ENTERTAINMENT INC (CZR) stock?

ChartMill assigns a valuation rating of 3 / 10 to CAESARS ENTERTAINMENT INC (CZR). This can be considered as Overvalued.


What is the profitability of CZR stock?

CAESARS ENTERTAINMENT INC (CZR) has a profitability rating of 3 / 10.


How financially healthy is CAESARS ENTERTAINMENT INC?

The financial health rating of CAESARS ENTERTAINMENT INC (CZR) is 1 / 10.